From: Reduction of eEF2 kinase alleviates the learning and memory impairment caused by acrylamide
Parameter | Exposed group (n = 50) | Non-exposed group (n = 50) | P |
---|---|---|---|
Subjective symptoms (n%) | |||
Hypomnesiab | 39(78.00) | 27(54.00) | 0.01 |
Unresponsiveb | 25(50.00) | 5(10.00) | < 0.0001 |
Giddyb | 31(62.00) | 14(28.00) | < 0.001 |
Headacheb | 27(54.00) | 5(10.00) | < 0.0001 |
Dreaminessb | 28(56.00) | 7(14.00) | < 0.0001 |
Hearing lossb | 32(64.00) | 6(12.00) | < 0.0001 |
Decreased visionb | 28(56.00) | 8(16.00) | < 0.0001 |
Melancholyb | 16(32.00) | 7(14.00) | 0.03 |